WallStreetZenWallStreetZen

NASDAQ: ITOS
Iteos Therapeutics Inc Stock Ownership - Who owns Iteos Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Iteos Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Matthew GallChief Financial Officer2024-11-195,000$7.73
$38.64kBuy
Boxer Capital LLCDirector2024-05-101,142,857$17.50
$20.00MBuy

1 of 1

ITOS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ITOS insiders and whales buy or sell their stock.

ITOS Shareholders

What type of owners hold Iteos Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Mpm Bioventures 2018 LP14.86%5,674,086$37.56MInsider
Mpm Bioventures 2014 LP14.86%5,674,086$37.56MInsider
Ansbert Gadicke11.74%4,484,728$29.69MInsider
Blackrock Inc9.95%3,801,509$25.17MInstitution
Boxer Capital LLC7.72%2,946,915$19.51MInsider
Mpm Asset Management LLC7.17%2,738,785$18.13MInstitution
Bvf Inc6.09%2,325,000$15.39MInstitution
Aaron I. Davis5.83%2,226,301$14.74MInsider
Ra Capital Management LP5.48%2,092,259$13.85MInstitution
Jpmorgan Chase Co5.42%2,068,796$13.70MInstitution

1 of 3

ITOS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ITOS59.30%40.70%Net Buying
AURA78.55%18.33%Net SellingNet Selling
MBX35.69%64.31%Net BuyingNet Buying
ATAI7.33%36.99%Net BuyingNet Buying
RNAC14.07%85.93%Net BuyingNet Buying
View Top Biotech Stocks

Iteos Therapeutics Stock Ownership FAQ

Who owns Iteos Therapeutics?

Iteos Therapeutics (NASDAQ: ITOS) is owned by 89.37% institutional shareholders, 61.34% Iteos Therapeutics insiders, and 0.00% retail investors. Mpm Bioventures 2018 LP is the largest individual Iteos Therapeutics shareholder, owning 5.67M shares representing 14.86% of the company. Mpm Bioventures 2018 LP's Iteos Therapeutics shares are currently valued at $42.27M.

If you're new to stock investing, here's how to buy Iteos Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.